Lin Xie

48 papers · 539 indexed citations

Immediate Impact

55 hit

Sub-graph 1 of 24

Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update

2025 Hit

Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy

2025 Hit

2 intermediate papers

Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity

2015

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lin Xie	265	252	173	123	111	48	539
Sonja Häckel	196 0.7×	168 0.7×	107 0.6×	66 0.5×	123 1.1×	39	484
Sharon J. Brown	270 1.0×	205 0.8×	164 0.9×	82 0.7×	90 0.8×	22	558
Jixian Qian	287 1.1×	258 1.0×	116 0.7×	95 0.8×	118 1.1×	43	572
Weiyong Gu	301 1.1×	214 0.8×	223 1.3×	156 1.3×	78 0.7×	41	587
Xin Wang	191 0.7×	256 1.0×	97 0.6×	58 0.5×	91 0.8×	47	572
Qinming Fei	299 1.1×	242 1.0×	155 0.9×	86 0.7×	88 0.8×	21	453
Chang‐Chin Wu	129 0.5×	207 0.8×	69 0.4×	95 0.8×	73 0.7×	26	496
Jiayi Lin	165 0.6×	151 0.6×	152 0.9×	73 0.6×	175 1.6×	33	580
Hongguang Xu	221 0.8×	235 0.9×	99 0.6×	71 0.6×	153 1.4×	36	544
Stefan Schären	248 0.9×	254 1.0×	198 1.1×	90 0.7×	38 0.3×	40	492

Loading papers...